93 related articles for article (PubMed ID: 30457585)
1. ATR-FTIR spectroscopy shows changes in ovarian cancer cells after incubation with novel organoamidoplatinum(ii) complexes.
Al-Jorani K; Rüther A; Haputhanthri R; Deacon GB; Li HL; Cullinane C; Wood BR
Analyst; 2018 Dec; 143(24):6087-6094. PubMed ID: 30457585
[TBL] [Abstract][Full Text] [Related]
2. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
Štarha P; Trávníček Z; Pazderová L; Dvořák Z
J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
[TBL] [Abstract][Full Text] [Related]
3. The Application of ATR-FTIR Spectroscopy and the Reversible DNA Conformation as a Sensor to Test the Effectiveness of Platinum(II) Anticancer Drugs.
Al-Jorani K; Rüther A; Martin M; Haputhanthri R; Deacon GB; Li HL; Wood BR
Sensors (Basel); 2018 Dec; 18(12):. PubMed ID: 30563229
[TBL] [Abstract][Full Text] [Related]
4. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting.
Zhang Y; Guo G; Ma B; Du R; Xiao H; Yang X; Li W; Gao Y; Li Y; Jing X
Anticancer Drugs; 2015 Aug; 26(7):698-705. PubMed ID: 25811961
[TBL] [Abstract][Full Text] [Related]
5. Studies on the activity of two Trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Huq F
Anticancer Res; 2012 Dec; 32(12):5331-6. PubMed ID: 23225434
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Ag(I) camphor sulphonylimine complexes and assessment of their cytotoxic properties against cisplatin-resistant A2780cisR and A2780 cell lines.
Cardoso JMS; Correia I; Galvão AM; Marques F; Carvalho MFNN
J Inorg Biochem; 2017 Jan; 166():55-63. PubMed ID: 27835775
[TBL] [Abstract][Full Text] [Related]
9. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
[TBL] [Abstract][Full Text] [Related]
10. A mitochondria-targeting hetero-binuclear Ir(iii)-Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells.
Ouyang C; Chen L; Rees TW; Chen Y; Liu J; Ji L; Long J; Chao H
Chem Commun (Camb); 2018 Jun; 54(49):6268-6271. PubMed ID: 29850704
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
[TBL] [Abstract][Full Text] [Related]
12. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of hydroxy- and sulfonamide-azobenzene platinum(II) complexes in cisplatin-resistant ovarian cancer cells.
Samper KG; Marker SC; Bayón P; MacMillan SN; Keresztes I; Palacios Ò; Wilson JJ
J Inorg Biochem; 2017 Sep; 174():102-110. PubMed ID: 28651169
[TBL] [Abstract][Full Text] [Related]
14. Synchrotron FTIR analysis of drug treated ovarian A2780 cells: an ability to differentiate cell response to different drugs?
Flower KR; Khalifa I; Bassan P; Démoulin D; Jackson E; Lockyer NP; McGown AT; Miles P; Vaccari L; Gardner P
Analyst; 2011 Feb; 136(3):498-507. PubMed ID: 21088767
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
[TBL] [Abstract][Full Text] [Related]
16. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
Cheng H; Huq F; Beale P; Fisher K
Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
[TBL] [Abstract][Full Text] [Related]
18. Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance.
Kalayda GV; Jansen BA; Molenaar C; Wielaard P; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2004 Jun; 9(4):414-22. PubMed ID: 15071768
[TBL] [Abstract][Full Text] [Related]
19. Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation.
Xie X; He G; Siddik ZH
Mol Cancer Res; 2017 Mar; 15(3):328-339. PubMed ID: 28031409
[TBL] [Abstract][Full Text] [Related]
20. Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin.
Horváth V; Soucek K; Svihálková-Sindlerová L; Vondrácek J; Blanárová O; Hofmanová J; Sova P; Kozubík A
Invest New Drugs; 2007 Oct; 25(5):435-43. PubMed ID: 17520175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
